View the CIPRODAS-250 registration information details.
Back to drug list
ItemsDrug Registration information
ID1213
No1213
Brand NameCIPRODAS-250
IngredientsCIPROFLOXACIN HYDROCHLORIDE USP EQ.TO CIPROFLOXACIN 250 MG/5 ML
Dosage FormPOWDER FOR SUSPENSION
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack Size60 ML/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsLOWER RESPIRATORY TRACT INFECTION DUE TO GRAM-NEGATIVE BACTERIA, CHRONIC SUPURATIVE OTITIS MEDIA, ACUTE EXACERBATION OF CHRONIC SINUSITIS, URINARY TRACT INFECTION, GENITAL TRACT INFECTION, INFECTION OF GASTRO-INTESTINAL TRACT, BONE AND JOINTS, SKIN AND SOFT TISSUE, INTR-ABDOMINAL INFECTION,
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE POWDER FORMING A YELLOW COLORED SUSPENSION ON ADDITION OF WATER
Note
License OwnerKONGCHAI-LAO PHARMA SOLE CO.,LTD
ManufacturerSALVAVIADAS PHARMACEUTICAL PVT.LTD
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No05 I 5926/25
FDD Registration Date19/05/2025
Expiry Date18/05/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA